Biotron Limited Delays Rights Issue Opening Amid ASIC Queries
I'm PortAI, I can summarize articles.
Biotron Limited has announced a delay in the opening of its rights issue due to queries from the Australian Securities and Investments Commission (ASIC). The new opening date is set for 17 March 2025, with further details to be confirmed. This delay may affect the company's fundraising efforts and operational plans. Biotron operates in the biotechnology sector, focusing on antiviral therapies. Current market cap is $4.54M, with a year-to-date price performance of 390.0%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments